STOCK TITAN
  1. Home
  2. Sec-filings
  3. RARE
  4. [4] – Horn Howard (CIK 0001786335)

[4] – Horn Howard (CIK 0001786335)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock RARE logo
Ultragenyx Pharm

NASDAQ:RARE

RARE Rankings

#1742 Ranked by Market Cap
N/A Ranked by Dividends

RARE Latest News

Oct 3, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 30, 2025
Ultragenyx Appoints Eric Olson as Chief Business Officer and Executive Vice President
Sep 19, 2025
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Sep 8, 2025
Ultragenyx Announces Positive Longer-term Data from Phase 3 Study of DTX401 AAV Gene Therapy for the Treatment of Glycogen Storage Disease Type Ia (GSDIa)
Aug 29, 2025
Ultragenyx to Participate at Investor Conferences in September

RARE Latest SEC Filings

Sep 19, 2025
[Form 4] Ultragenyx Pharmaceutical Inc. Insider Trading Activity
Sep 19, 2025
[Form 4] Ultragenyx Pharmaceutical Inc. Insider Trading Activity
Sep 8, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event
Sep 8, 2025
[Form 4] Ultragenyx Pharmaceutical Inc. Insider Trading Activity
Aug 18, 2025
[8-K] Ultragenyx Pharmaceutical Inc. Reports Material Event

RARE Stock Data

3.09B
91.74M
3.14%
101.49%
8.63%
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO